DTP

CTCP Dược phẩm CPC1 Hà Nội · UPCOM
77,300 Latest close · 30 Jun 2026 P/E 8.5x P/B 2.0x
Slightly positive · CFO/NPAT 1.22x

On a TTM 2026Q1 basis, DTP is showing a few mildly positive signals versus the same period, though the magnitude is narrow — the growth momentum has held across consecutive periods. The direction is leaning toward improvement, but the next test will be whether the magnitude widens enough to become a trend.

Revenue TTM
VND 1,778bn
+32.8%
Net Margin
16.63%
−1.1pp year on year
ROE
26.0%
TTM

Same sector PHARMACEUTICALS